Discover Insmed's innovative therapies targeting rare diseases, with approvals like Brinsupri boosting potential.

Even after a recent rally, Chinese indexes have only just returned to levels seen in the aftermath of a dramatic bubble burst ...

SSR Mining’s strong liquidity, low leverage, and solid asset performance position it for upside in a strong metals cycle.

Alphabet posted strong Q2 results with rapid Cloud growth, solid earnings, and low valuation, offering major upside potential ...